MoonLake Immunotherapeutics

MLTX • NASDAQ

MoonLake Immunotherapeutics is a biotechnology company in the healthcare sector on NASDAQ, led by Jorge Santos da Silva, with a market cap of $1.2B. As of Q3 2025, 59% of shares are held by 133 institutional investors, with BVF INC/IL as the largest holder at 31.1%.

CEOJorge Santos da Silva

Market Cap$1.2B

Biotechnology

Healthcare

Employees50.0

Websitemoonlaketx.com

Country

United States of America

Overview

Overview of institutional ownership in MLTX as of Q3 2025 with a market cap of $455.3M

All Institutions

Institutions: 133
Value Held: $269.0M
Shares Held: 37.5M
Avg Position: $2.0M
Median Position: $180.5K

Hedge Funds

Hedge Funds: 30
Value Held: $52.9M
Shares Held: 7.4M
Avg Position: $1.8M
Median Position: $387.7K

Ownership Breakdown

Institutional (non-HF)

47.46%

$216.1M

Hedge Funds

11.62%

$52.9M

Retail & Other

40.92%

$186.3M

Based on market cap of $455.3M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in MLTX as of Q3 2025

Institution	Key People	Position Value	Ownership	Owned Since	Total AUM (Long)
B BVF INC/IL Institution	-	$141.6M 5.74% of portfolio	31.10% 19.8M shares	Q2 2022 Held for 3y 6m	$2.5B
venBio Select Advisor LLC RIA/Wealth	Behzad Aghazadeh Managing Partner	$14.3M 0.19% of portfolio	3.15% 2.0M shares	Q2 2023 Held for 2y 6m	$7.7B
C Cormorant Asset Management, LLC Hedge Fund•Long/Short	Bihua Chen CEO	$14.3M 1.11% of portfolio	3.14% 2.0M shares	Q2 2022 Held for 3y 6m	$1.3B
BALYASNY ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy	Dmitry Balyasny CIO	$12.2M 0.03% of portfolio	2.68% 1.7M shares	Q3 2022 Held for 3y 3m	$48.1B
A ADAGE CAPITAL PARTNERS GP LLC Institution	-	$10.8M 0.02% of portfolio	2.36% 1.5M shares	Q3 2025 Held for 3 months	$63.0B
Schonfeld Strategic Advisors LLC Hedge Fund•Multi-Strategy	Ryan Andrew Tolkin CEO	$6.9M 0.05% of portfolio	1.52% 965.4K shares	Q1 2023 Held for 2y 9m	$14.3B
PRICE T ROWE ASSOCIATES INC /MD/ Long Only Manager	Robert W Sharps President	$5.9M 0.00% of portfolio	1.30% 823.0K shares	Q2 2022 Held for 3y 6m	$912.31B
FMR LLC Institution	-	$5.2M 0.00% of portfolio	1.14% 726.9K shares	Q2 2022 Held for 3y 6m	$1.92T
N Nuveen, LLC Institution	-	$4.6M 0.00% of portfolio	1.00% 635.7K shares	Q1 2025 Held for 9 months	$377.99B
TWO SIGMA INVESTMENTS LLC Hedge Fund•Multi-Strategy	Scott David Hoffman CEO	$3.3M 0.01% of portfolio	0.72% 454.3K shares	Q1 2025 Held for 9 months	$62.0B

Net Capital Flow

Institutional buying and selling activity for MLTX in Q3 2025

Traded: −$528.8M
Buyers: 88
Sellers: 79
Total Bought: +$59.9M
Total Sold: −$588.7M
Avg Position: $1.5M

Biggest Buyers

Institution	Net Bought	Current Position
A ADAGE CAPITAL PARTNERS GP LLC Institution	+$10.8M +1.5M shares	$10.8M 1.5M shares
BALYASNY ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy	+$9.1M +1.3M shares	$12.2M 1.7M shares
Schonfeld Strategic Advisors LLC Hedge Fund•Multi-Strategy	+$6.9M +965.4K shares	$6.9M 965.4K shares
TWO SIGMA INVESTMENTS LLC Hedge Fund•Multi-Strategy	+$3.3M +454.3K shares	$3.3M 454.3K shares
Ikarian Capital, LLC Hedge Fund•Event Driven	+$3.1M +435.8K shares	$3.1M 435.8K shares
F First Turn Management, LLC Hedge Fund•Long/Short	+$1.9M +262.6K shares	$1.9M 262.6K shares
BOOTHBAY FUND MANAGEMENT, LLC Fund of Funds	+$1.9M +258.8K shares	$1.9M 258.8K shares
Boxer Capital Management, LLC Hedge Fund•Long/Short	+$1.8M +250.0K shares	$1.8M 250.0K shares
Verition Fund Management LLC Hedge Fund•Multi-Strategy	+$1.8M +249.2K shares	$2.0M 272.8K shares
MORGAN STANLEY RIA/Wealth	+$1.5M +213.4K shares	$1.8M 256.7K shares

Biggest Sellers

Institution	Net Sold	Current Position
WESTFIELD CAPITAL MANAGEMENT CO LP Long Only Manager	−$59.4M −1.3M shares	Sold Off 0 shares
FEDERATED INVESTORS INC /PA/ Long Only Manager	−$58.9M −1.2M shares	Sold Off 0 shares
ALLIANCEBERNSTEIN L.P. Long Only Manager	−$53.7M −1.1M shares	Sold Off 0 shares
C Cormorant Asset Management, LLC Hedge Fund•Long/Short	−$46.6M −6.5M shares	$14.3M 2.0M shares
Paradigm Biocapital Advisors LP Hedge Fund•Long/Short	−$41.5M −878.3K shares	Sold Off 0 shares
FMR LLC Institution	−$35.9M −5.0M shares	$5.2M 726.9K shares
RTW INVESTMENTS, LLC Hedge Fund•Sector	−$35.0M −741.1K shares	Sold Off 0 shares
Hood River Capital Management LLC Long Only Manager	−$31.9M −675.4K shares	Sold Off 0 shares
Vestal Point Capital, LP Hedge Fund•Long/Short	−$26.0M −550.0K shares	Sold Off 0 shares
S Siren, L.L.C. Institution	−$24.0M −508.3K shares	Sold Off 0 shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited MLTX in Q3 2025

New Positions: 25
New Value: $9.4M
Exited Positions: 46
Exited Value: $461.5M

New Positions

Institution	Position Value
Ikarian Capital, LLC Hedge Fund•Event Driven	$3.1M 435.8K shares
BOOTHBAY FUND MANAGEMENT, LLC Fund of Funds	$1.9M 258.8K shares
Boxer Capital Management, LLC Hedge Fund•Long/Short	$1.8M 250.0K shares
S SPHERA FUNDS MANAGEMENT LTD. Institution	$509.1K 71.0K shares
PRINCIPAL FINANCIAL GROUP INC Institution	$508.7K 70.9K shares
L Lion Point Capital, LP Hedge Fund•Event Driven	$484.0K 67.5K shares
Voleon Capital Management LP Hedge Fund•Quant	$288.8K 40.3K shares
T TWO SIGMA SECURITIES, LLC Institution	$261.0K 36.4K shares
A AXIOM INTERNATIONAL INVESTORS LLC /DE Long Only Manager	$180.5K 25.2K shares
M MYDA Advisors LLC Hedge Fund•Long/Short	$107.6K 15.0K shares

Exited Positions

Institution	Previous Position
WESTFIELD CAPITAL MANAGEMENT CO LP Long Only Manager	$59.4M 1.3M shares
FEDERATED INVESTORS INC /PA/ Long Only Manager	$58.9M 1.2M shares
ALLIANCEBERNSTEIN L.P. Long Only Manager	$53.7M 1.1M shares
Paradigm Biocapital Advisors LP Hedge Fund•Long/Short	$41.5M 878.3K shares
RTW INVESTMENTS, LLC Hedge Fund•Sector	$35.0M 741.1K shares
Hood River Capital Management LLC Long Only Manager	$31.9M 675.4K shares
Vestal Point Capital, LP Hedge Fund•Long/Short	$26.0M 550.0K shares
S Siren, L.L.C. Institution	$24.0M 508.3K shares
MPM Oncology Impact Management LP Institution	$14.8M 313.6K shares
F FRED ALGER MANAGEMENT INC Long Only Manager	$14.0M 295.6K shares

Options Activity

Institutions with the largest Call and Put options positions in MLTX as of Q3 2025

Call Positions: 27
Call Value: $29.6M
Put Positions: 12
Put Value: $11.0M

Call Positions

Institution	Position Value
J JANE STREET GROUP, LLC Institution	$5.8M 8.1K contracts
Ikarian Capital, LLC Hedge Fund•Event Driven	$4.4M 6.1K contracts
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity	$4.0M 5.5K contracts
Caption Management, LLC Hedge Fund•Long/Short	$2.8M 4.0K contracts
TORONTO DOMINION BANK Institution	$2.3M 3.2K contracts
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy	$2.2M 3.0K contracts
BOOTHBAY FUND MANAGEMENT, LLC Fund of Funds	$1.7M 2.4K contracts
Walleye Trading LLC RIA/Wealth	$1.0M 1.5K contracts
Centiva Capital, LP Hedge Fund•Multi-Strategy	$952.9K 1.3K contracts
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC Hedge Fund•Long/Short	$717.0K 1.0K contracts

Put Positions

Institution	Position Value
Ikarian Capital, LLC Hedge Fund•Event Driven	$3.2M 4.5K contracts
BOOTHBAY FUND MANAGEMENT, LLC Fund of Funds	$1.9M 2.6K contracts
Caption Management, LLC Hedge Fund•Long/Short	$1.8M 2.5K contracts
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy	$1.4M 2.0K contracts
L LMR Partners LLP Institution	$1.0M 1.5K contracts
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity	$775.1K 1.1K contracts
Walleye Trading LLC RIA/Wealth	$430.9K 601.0 contracts
TUDOR INVESTMENT CORP ET AL Hedge Fund•Multi-Strategy	$222.3K 310.0 contracts
Hudson Bay Capital Management LP Hedge Fund•Multi-Strategy	$143.4K 200.0 contracts
N NOMURA HOLDINGS INC Institution	$71.7K 100.0 contracts

Most Committed Institutions

Institutions with MLTX as the highest % of their portfolio as of Q3 2025

Institution	Key People	Portfolio Weight	Ownership	Owned Since	Total AUM (Long)
B BVF INC/IL Institution	-	5.74% $141.6M	31.10% 19.8M shares	Q2 2022 Held for 3y 6m	$2.5B
L Lion Point Capital, LP Hedge Fund•Event Driven	Carl Didric Marcus Cederholm CIO	2.75% $484.0K	0.11% 67.5K shares	Q3 2025 Held for 3 months	$17.6M
C Cormorant Asset Management, LLC Hedge Fund•Long/Short	Bihua Chen CEO	1.11% $14.3M	3.14% 2.0M shares	Q2 2022 Held for 3y 6m	$1.3B
Exome Asset Management LLC Hedge Fund•Sector	Alex R Forschner President	0.86% $1.3M	0.28% 178.1K shares	Q3 2025 Held for 3 months	$148.0M
Ikarian Capital, LLC Hedge Fund•Event Driven	Neil Tristan Shahrestani CEO	0.63% $3.1M	0.69% 435.8K shares	Q1 2025 Held for 9 months	$494.3M
Boxer Capital Management, LLC Hedge Fund•Long/Short	Aaron Isaac Davis CEO	0.59% $1.8M	0.39% 250.0K shares	Q3 2025 Held for 3 months	$303.5M
Caitong International Asset Management Co., Ltd RIA/Wealth	Dusan Thomas Zachystal CEO	0.42% $606.2K	0.13% 84.6K shares	Q1 2025 Held for 9 months	$144.7M
F First Turn Management, LLC Hedge Fund•Long/Short	Lisa Gable Wheatley Managing Partner	0.28% $1.9M	0.41% 262.6K shares	Q1 2025 Held for 9 months	$666.0M
Decheng Capital LLC Venture Capital	Xiangmin Nmn Cui Managing Partner	0.23% $1.3M	0.29% 181.6K shares	Q1 2024 Held for 1y 9m	$573.2M
venBio Select Advisor LLC RIA/Wealth	Behzad Aghazadeh Managing Partner	0.19% $14.3M	3.15% 2.0M shares	Q2 2023 Held for 2y 6m	$7.7B

Hedge Fund Spotlight

Discover hedge funds investing in MLTX

SILVERARC CAPITAL MANAGEMENT, LLC

Hedge Fund • Long/Short

Portfolio ManagerDevesh Sharad Gandhi

Portfolio Value: $689.7M
Positions: 72
Last Reported: Q3 2025

Sector Allocation

Position in MoonLake Immunotherapeutics

Market Value: $215.1K
Shares Held: 30.0K
Portfolio Weight: 0.03%
Owned Since: 2025-Q2

Top Holding	Sector	Market Value	Weight
1 ABVX Abivax ABVX	Unknown Unknown	$45.8M	6.64%
2 Rhythm Pharmaceuticals, Inc. RYTM	Biotechnology Healthcare	$37.4M	5.42%
3 Avidity Biosciences RNA	Biotechnology Healthcare	$36.8M	5.34%

View full profile

MoonLake Immunotherapeutics

Overview

All Institutions

Hedge Funds

Ownership Breakdown

Biggest Investors

Net Capital Flow

Biggest Buyers

Biggest Sellers

Entry and Exit Activity

New Positions

Exited Positions

Options Activity

Call Positions

Put Positions

Most Committed Institutions

Hedge Fund Spotlight

Position in MoonLake Immunotherapeutics

Cookie Preferences